Table 4.
Study | Target | Core needle size (G) | DCIS at CNB/total number of biopsied cases (%) | Total number underestimated (%) |
---|---|---|---|---|
Smith et al., 2001 [3] | Breast mass subtracting calcifications only | 14 | 5/128 (1) | 1/5 (20) |
Schoonjans and Brem, 2001 [24] | Breast masses | 14 | 9/424 (2.1) | 5/9 (55.5) |
Buchberger et al., 2002 [25] | Breast masses and calcifications | 14 | 10/590 (1.7) | 3/10 (30) |
Philpotts et al., 2003 [23] | Breast lesions (primarily breast masses) | 14 | 2/181 (1.1) | 1/2 (50) |
Pijnappel et al., 2004 [22] | Breast mass and calcifications only | 14 or 18 | 8/128 (6.3) | 5/8 (62.5) |
Crystal et al., 2005 [21] | Breast masses | 14 | 6/715 (0.8) | 4/6 (66.7) |
Sauer et al., 2005 [20] | Breast masses | 14 | 19/962 (2.0) | 11/19 (57.9) |
Cho et al., 2005 [19] | Breast mass (n=551) and calcifications (n=11) | 14 | 10/562 (1.8) | 5/10 (50) |
Youk et al., 2008 [26] | Breast masses subtracting calcifications only | 14 | 126/2420 (5.2) | 36/126 (29) |
Schueller et al., 2008 [18] | Non-palpable breast masses | 14 | 52/1,061 (4.9) | 19/52 (36.5) |
Current study | Breast mass subtracting calcifications only | 14 | 69/3,124 (2.2) | 21/69 (30.4) |
DCIS, ductal carcinoma in situ; CNB, core needle biopsy; G, gauge.